NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00004932 2014-02-21STI571 in Treating Patients With Recurrent LeukemiaChildren's Oncology GroupPhase 1 Completed31 enrolled
NCT01066468 2012-03-13Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.NovartisPhase 1 Terminated3 enrolled